Skip to content
Company Terminals Nifty 50 Company TerminalsNifty 500 Index TerminalRecently Listed IPOs Markets Bhav Dhan Index: fear and greed, decodedFII DII data today, decodedNifty P/E, measured five waysMorning Open: before the bellEvening Close: the day, readThis season's results, read forensicallyAlerts by email and TelegramMarket Movers: why stocks moved IPO Intel Live and upcoming IPOsRecently listed: score vs outcomeSME IPO forensics Research Research and analysisIndustry research Calculators All calculatorsGold desk Services Roadmap Pricing Get started →
The $13 Billion Machine: Inside the Macro-Economics of the 2026 FIFA World CupAlibaba share price is up 16% today. what next for Baba stock?IPO Allotment status check online by PAN number 2025UnitedHealth (UNH Stock): You should stay away from itQ4 results live updates: Adani Group companies in focusThe $13 Billion Machine: Inside the Macro-Economics of the 2026 FIFA World CupAlibaba share price is up 16% today. what next for Baba stock?IPO Allotment status check online by PAN number 2025UnitedHealth (UNH Stock): You should stay away from itQ4 results live updates: Adani Group companies in focus
NSE: UPLISIN INE628A01036

UPL Ltd.

ChemicalsNifty 500Statement-builtBalanced risk
₹534.65
−6.40 (−1.18%)
Close 2026-10-16
52-week range
₹481−33.6% from high₹805
Last 6 months −19.6%
Trend
vs 50-DMA −3.2%vs 200-DMA −12.3%Volatility 35%
Analyst view from the market data feed
94% bullish
16 analystsmean rating 1.75
Price
₹534.65
Mkt cap
₹45,378 cr
P/E (TTM)
23.0xexcl. exceptional items
P/B
1.32x
Book value
₹408.8
ROE
5.8%
Op margin
12.3%
Net margin
4.4%
D/E
0.67
Div yield
1.11%
Q2 FY27 results3 questions to askHide
Revenue₹11,860 cr▼ 1.3%on the year▲ 16.5%on the quarter
EBITDA₹2,200 cr▲ 9.9%on the yearmargin 18.5% (+190 bps)
Net profit₹452 cr▼ 26.1%on the year
EPS₹4.99▼ 26.1%on the year
  1. Revenue ₹11,860 cr, −1.3% on the year (this quarter has averaged +8.7% over the last 2 years); EBITDA margin 18.5%, +190 bps.
  2. Part of the profit growth came from outside the business: reported −26.1%, core −36.7%. Other income, exceptional items or tax added 11 points.
  3. Profit with no operating cash behind it. Where did the cash go? Operating cash flow for the first half −₹9,587 cr against profit of ₹379 cr.
!Profit with no operating cash behind it. Where did…?Inventory is piling up against sales. Slow demand, or…?Receivables grew much faster than sales. Who has not…
Management said
  • UPL delivered its eighth consecutive quarter of improvement in margins and EBITDA grew 5% in the quarter and 9% in the first half with margins expanding by 120 and 80…concall
  • Advanta, our seeds and post-harvest platform, has agreed to acquire 99.98% of Misr Hytech Seed International in Egypt for approximately $110 million.concall
  • S&P revised the outlook on UPL Corp to positive from stable affirming its BB rating and CRISIL revised the outlook on UPL Limited to stable affirming its AA+ and A1+…concall
Market today: Funded rallyBhav 58 · Dhan 70 · 6 NovBhav Dhan Index →
Consolidatedstandalone figures are read separately and never mixed into these tables
What this company actually does

A plain-language read of the business, how it actually earns, where the edge is, and the economics of every reported segment — taken from the annual report and investor presentation, not a one-line industry label.

  • Business model in plain language
  • The revenue engine — what actually generates cash
  • Segment revenue, PBIT, margin and capital employed
  • Operating KPIs — volumes, capacity, utilisation
Live once this company's filings, calls and disclosures have been read.

What's newsince the last filing we processed

Annual report Annual Report 2026 Open
Earnings call Oct 2022 Open

Price in context split-adjusted

1M−2.9%
6M−18.6%
1Y−21.4%-21.4% a year
From high−33.6%worst -40%
vs Nifty, 1Y−19.3 ptsNifty −2.2%
Beta1.19vs Nifty 50
Volatility35%a year

Trading at 49.2x earnings against its own median of 74.7x: 0.3 standard deviations below its usual range. This compares the company with its own history, not with other companies.

How to read this: Price shows the closing price with its 50-day (amber) and 200-day (grey) averages; bars at the bottom are daily volume, green on up days and red on down days; dashed lines mark the 52-week high and low. vs Nifty 50 starts both at 100 so you can see which did better over the period. P/E shows what the market paid for each rupee of profit, inside the band it usually trades in. Drawdown shows how far below its best price the share has been. Hover anywhere for the numbers on that day.

Events marked on the chart 3
  1. 1Bonus 1:1corporate action · 2008-10-29
  2. 2Bonus 1:2corporate action · 2019-07-02
  3. 3Rights 1:8corporate action · 2024-11-26
What you must understand

The three to six things that actually matter about this company, each with the exact filing and note it came from — never a fact without the context that makes it meaningful.

  • Reported profit vs operating profit
  • Management narrative vs the numbers
  • Standalone vs consolidated divergence
  • Audit opinion vs headline optimism
Live once this company's filings, calls and disclosures have been read.

Reading the Statements forensic interpretation

What the numbers mean when read together — computed from the filings, not a score.

Operating cash flow backs the profit

Operating cash is 354% of trailing profit — the earnings are converting to real cash, not just accruals.

Why this reading: A positive signal: cash conversion at or above ~0.9 means reported profit is showing up as actual cash.

Full read

Operating cash ₹7,855 cr against trailing net profit ₹2,220 cr. Consistent conversion near or above 1.0 is a hallmark of genuine earnings.

Profit growing with revenue

Both revenue and profit grew over the last year (12.9% and 98.4%) — growth is translating to the bottom line.

Why this reading: A positive signal in the numbers, shown for balance alongside the concerns.

Full read

Trailing revenue ₹52,804 cr, trailing profit ₹2,323 cr. Profit growing at least as fast as revenue indicates operating leverage or pricing power.

Generates free cash

Free cash flow is positive and consistent — the business funds itself after capex.

Why this reading: A positive signal in the numbers, shown for balance alongside the concerns.

Full read

Latest free cash flow ₹5,502 cr. Negative in only 0 of 12 years. A self-funding business needs less external capital and dilutes less.

Deleveraging

Borrowings have fallen 21% over two years — the balance sheet is getting lighter.

Why this reading: A positive signal in the numbers, shown for balance alongside the concerns.

Full read

Borrowings down to ₹23,576 cr from ₹29,754 cr. Falling debt reduces finance cost and financial risk.

Forensic modelscomputed from the filed statements

Every score below is calculated here from the reported numbers — none of it is asserted. Open the notebook at the foot of the section to see each formula with this company's figures in it.

Altman Z″

Needs current assets and current liabilities.

Piotroski F

7 / 8 1 not testable
  • Profitable this year
  • Operating cash positive
  • Return on assets improved
  • Cash exceeds profit
  • Leverage reduced
  • Liquidity improved
  • No share dilution
  • Margin improved
  • Assets working harder
What is this, and how do I read it?

Piotroski F-Score — fundamental momentum — Joseph Piotroski, University of Chicago, 2000, in a study of whether accounting signals could improve returns among cheap stocks.

Nine yes-or-no tests across profitability, leverage and operating efficiency. Each pass scores one. It asks a narrow question: is this business getting better or worse on its own terms, year over year?

Profitability (4 tests)
Positive profit, positive operating cash, improving return on assets, and cash exceeding profit. The last is the quality test — profit that outruns cash is the one to question.
Leverage and liquidity (3 tests)
Falling debt, improving current ratio, no new shares issued. Growth funded by dilution scores zero here.
Operating efficiency (2 tests)
Improving margin and improving asset turnover.

How to read it7 or more suggests improving fundamentals; 3 or fewer suggests deterioration. It measures direction, not quality — a weak company improving can score higher than a strong one holding steady.

Where it failsA single year of comparison, so one unusual year distorts it. Says nothing about valuation, competitive position or management. Piotroski designed it to rank already-cheap stocks, not to judge a company in isolation.

Beneish M

Needs trade receivables, current assets, other expenses.

Cash vs profit

2.64× 12-year cumulative

Accruals are -6.3% of assets. Free cash flow negative in 0 of 12 years.

DuPont — return on equity FY2026

Net margin4.3%× Asset turnover0.56×× Leverage2.68×= ROE6.4%
What is this, and how do I read it?

DuPont decomposition — Devised inside the DuPont Corporation in the 1920s and still the standard way to read a return on equity.

Splits return on equity into its three sources, so the same headline number can be traced to very different businesses.

Net margin
What the company keeps from each rupee of sales. High margin points to pricing power or a genuine cost advantage.
Asset turnover
Sales generated per rupee of assets. High turnover points to efficiency — a retailer earns this way, a utility never will.
Leverage (equity multiplier)
Assets divided by equity. This multiplies whatever the first two produce, in both directions.

How to read itA 20% ROE built on margin and turnover is a different proposition from a 20% ROE built on 3× leverage. The first survives a downturn; the second amplifies it.

Where it failsA single year. Negative equity makes it meaningless. Leverage is structural for lenders, so the third term carries no signal there.

Leverage & coverage FY2026

Debt / equity0.68×
Interest coverage1.93×
ROCE10.0%

Capital that builds FY2023 → FY2026

Capital deployed+9%
Revenue produced+-3%
Still in CWIP₹3,147 cr

Capital and revenue are growing at broadly similar rates — the asset base is being used, not just added to.

The formula notebook — every number above, worked out
Cash vs profit cumulative operating cash flow ÷ cumulative net profit ₹61,110 cr ÷ ₹23,163 cr, over 12 years 2.64× Above 1.0 means cash exceeds reported profit — the healthier reading.
Accruals (Sloan) (net profit − operating cash flow) ÷ average total assets (₹2,220 − ₹7,855) cr ÷ average assets -6.3% Negative means cash exceeded profit — the healthier reading. Positive above ~10% is where accruals start to dominate earnings.
DuPont — return on equity net margin × asset turnover × leverage 4.3% × 0.56 × 2.68 6.4% Splits ROE into whether returns come from operations or from borrowing.
Interest coverage EBIT ÷ finance cost ₹6,558 cr ÷ ₹3,401 cr 1.93× How many times operating profit covers the interest bill.
Debt to equity borrowings ÷ net worth ₹23,576 cr ÷ ₹34,696 cr 0.68× Read against the sector — infrastructure carries more than software.
Capital that builds growth in fixed assets + CWIP, against growth in revenue capital +9% vs revenue +-3%, FY2023 to FY2026 12pp gap Money going in far faster than revenue coming out. For an incubator this is expected — the test is whether it eventually converts.

Going deepersame statements, harder questions

Montier C-Score

Needs more balance-sheet detail (only 3 of 6 flags testable).

Return on invested capital FY2026

ROIC8.4%
On new capital since FY2023 -15.6%
Capital employed₹58,272 cr

NOPAT over equity plus debt less cash, at a notional 25% tax. Incremental ROIC is the return on money put in since then — the number that decides whether growth creates value or consumes it.

What is this, and how do I read it?

Return on invested capital, and incremental ROIC — Standard in corporate finance; the incremental form was popularised by Michael Mauboussin as the test of whether growth creates value.

ROIC measures what the business earns on all the capital it employs — equity plus debt, less cash. Incremental ROIC asks a sharper question: what has it earned on the money put in since a chosen year?

NOPAT
Operating profit after a notional tax charge, so the figure is independent of how the company is financed. We use 25%.
Invested capital
Equity plus borrowings less cash — the money actually at work.
Incremental ROIC
Change in NOPAT divided by change in invested capital. If it sits below the cost of capital, growth is destroying value however fast revenue rises.

How to read itROIC comfortably above the cost of capital — call it 11–13% in India — means growth compounds. Below it, growth consumes. Incremental below headline means recent investment is earning less than the legacy business.

Where it failsDistorted in the year of a large acquisition. Understated for companies mid-build, where capital is deployed but capacity has not yet been commissioned — an incubator will look poor until it does not.

Earnings quality ladder FY2026

Cash ÷ EBITDA0.87×
Cash ÷ profit3.54×
Free cash ÷ profit2.48×

Read downward. Cash can cover EBITDA and still not survive capex — the third rung is where a capital-hungry business shows itself.

What is this, and how do I read it?

The earnings quality ladder — Not a named model — the standard sequence an analyst walks when testing whether reported profit is real.

Three ratios read in order, each stricter than the last.

Cash ÷ EBITDA
Does operating profit arrive as cash? Below 0.8 points to working capital absorbing it.
Cash ÷ profit
Does bottom-line profit arrive as cash? Below 1.0 persistently is the classic warning.
Free cash ÷ profit
Does anything survive capex? This is where capital-hungry businesses reveal themselves — a company can pass the first two and still never generate spendable cash.

How to read itRead downward. Each rung failing where the one above passed tells you exactly where the cash is going.

Where it failsA single year of heavy capex depresses the third rung legitimately. Judge it across a cycle.

What the price implies

-3.4% free cash flow growth, every year for ten years

The growth rate that makes today's market value equal the discounted cash flows, at a 11.5% discount rate and 4.0% terminal growth. Not a forecast — the arithmetic of what is already in the price. Compare it with what the business has actually delivered.

What is this, and how do I read it?

Reverse DCF — the growth already in the price — A standard inversion of discounted cash flow, used to avoid the forecasting problem entirely.

Instead of forecasting cash flows and deriving a value, it takes today's market value as given and solves for the growth rate that would justify it. The output is not a view — it is the arithmetic of what the market is currently assuming.

Discount rate
The return required for the risk taken. We use 11.5%, roughly the long-run cost of equity in India.
Terminal growth
Growth beyond the explicit ten years. We use 4%, near long-run nominal GDP.
The output
The free-cash-flow growth rate, every year for a decade, that makes the discounted total equal today's market value.

How to read itCompare it with what the business has actually delivered. A price implying 30% a year against a decade of 15% is a demanding assumption; the reverse is a modest one.

Where it failsUseless when free cash flow is negative or unusually depressed, which is common mid-capex. Highly sensitive to the discount rate — a point either way moves the answer materially.

Cost of debt FY2026

Interest ÷ average borrowings13.97%
Average borrowings₹24,338 cr

Against a policy rate near 6%, most sound Indian corporates borrow between 7% and 10%.

What is this, and how do I read it?

Cost of debt — Interest expense over average borrowings — the effective rate the company actually pays.

What the lenders charge, which is a market verdict on credit quality that no rating agency delay affects.

Well below the policy rate
Suggests interest is being capitalised into assets rather than expensed, or that funding comes from related parties on non-market terms.
Near the policy rate plus a normal spread
Ordinary bank funding. Nothing to explain.
Well above
Lenders are pricing risk the equity market may not yet be.

How to read itAgainst a policy rate near 6%, most sound Indian corporates borrow between 7% and 10%. Read the direction over years as much as the level.

Where it failsUnderstated where a large share of interest is capitalised into projects under construction. Not meaningful for lenders, where interest is cost of goods.

Reading the numbers on this pagetwo bases, both shown

Some figures appear twice on this page with different values. That is not an error — they sit on different bases. The live feed reports a rolling twelve months; everything computed here comes from the last audited statements. Both are shown so you can see which is which.

Operating margin
Trailing twelve months, live feed12.3%
FY2026, as filed17.5%
5.2% apart

Where the two disagree, every model, screen and ratio computed on this page uses the filed figure, because the rest of the page is on that basis.

What the filings we hold do not give

Models that need these lines are withheld rather than estimated: net worth, current assets, current liabilities, trade receivables, inventory, net block. Nothing on this page is back-solved from a figure the company did not publish.

Published screening frameworksrules applied, not opinions quoted

Each framework below is a set of stated, mechanical criteria from published work, run against this company's own filed numbers. Passing or failing a screen is not a verdict — different frameworks disagree by design, and that disagreement is itself informative.

Graham — defensive investor

1 / 5
  • Debt below net worth ₹23,576 cr vs ₹34,696 cr
  • Positive earnings every year 11 of 12 years
  • Earnings growth over the period -50% since FY2022
  • P/E below 15 23.0×
  • P/E × P/B below 22.5 30.4

Benjamin Graham's stated criteria for a defensive stock, applied to the filed numbers. A company failing several is not disqualified — Graham designed these to be deliberately strict.

Greenblatt — magic formula

0 / 2
  • Return on capital above 20% 11.3%
  • Earnings yield above 8% 4.3%

Two ratios only: what the business earns on its capital, and what you pay for those earnings. Designed to be ranked across a universe rather than read in isolation.

O'Neil — CAN SLIM growth tests

1 / 4
  • Annual earnings growth above 25% 115%
  • Revenue growth above 20% 11%
  • Return on equity above 17% 6.4%
  • Share count not expanding equity capital ₹169 cr

The fundamental half of William O'Neil's framework. The market and leadership components are judgement calls and are not scored here.

Quality — compounder tests

1 / 4
  • Cash conversion above 0.9× 2.64× over 12 years
  • ROCE above 15% 10.0%
  • Interest covered more than 4× 1.93×
  • Debt below half of equity 0.68×

The characteristics long-term holders commonly look for: cash-backed earnings, high returns on capital, and debt that never forces a decision.

Against the sector29 companies

Median of the companies we hold in the same sector (Chemicals). Every figure on both sides is the live feed's trailing twelve months, so the two are measured the same way whatever depth of extraction this company has had. A number only means something next to something else — expensive against the market and cheap against peers are different facts.

P/E
23.0×
33.9×
-32%
P/B
1.3×
5.0×
-73%
Return on equity
5.8%
15.7%
-63%
Operating margin
12.3%
15.0%
-18%
Net margin
4.4%
11.8%
-63%
Dividend yield
1.1%
0.5%
+131%
this companysector median

The page in pictures

Revenue and what it leaves behind

Bars are revenue; the line is net margin. Revenue rising while the line falls is the shape worth noticing.

FY19 · 21,837FY19FY20 · 35,756FY20FY21 · 38,694FY21FY22 · 46,240FY22FY23 · 53,576FY23FY24 · 43,098FY24FY25 · 46,637FY25FY26 · 51,839FY26
Revenue (₹ cr)Net margin %

Where the year's cash went — FY2026

Operating cash first, then what the business spent and raised.

7,855Operating cash−1,475Investing−9,883Financing

Quality over time

One year is a snapshot. These are the two lines that matter across a cycle.

148.42.8-2.9FY19FY20FY21FY22FY23FY24FY25FY26
Cash ÷ profit (×)ROCE (÷10)

Where cash gets stuck

Rising debtor or inventory days against flat sales is the earliest visible sign of stress.

36324813318FY19FY20FY21FY22FY23FY24FY25FY26
Debtor daysInventory daysPayable daysCash cycle
Growth & valuation workspace

Set your own assumptions and watch the numbers move. A scenario calculator — the outputs are the arithmetic of your inputs.

User-driven scenario tool. Implied value and CAGR follow only from the assumptions you set — not a FinMinutes forecast, recommendation, or target price.

Valuation & quality

One canonical set of figures — the same numbers used everywhere else on this page and on the screener.

What you payHow the price compares with earnings, book and sales.
P/E (TTM)
23.0x
trailing 12m, live feed
P/B
1.32x
P/S
0.87x
Dividend yield
1.11%
What it earnsMargins and returns as the live feed reports them, on a rolling twelve months. The models above compute the same measures from the last audited statements, so the two can differ.
Operating margin
12.3%
trailing 12m, live feed
Net margin
4.4%
trailing 12m, live feed
Return on equity
5.8%
trailing 12m, live feed
How it is fundedLeverage and what is returned to shareholders.
Debt / equity
0.67
moderate
Payout ratio
25.1%
Book value / share
₹408.8
Return on equity of 5.8% is built on a 4.4% net margin and debt of 0.67x equity. The full DuPont breakdown sits in the forensic models above.

Ownership & Skin in the Game

How the register has moved over recent quarters — the direction matters more than the level.

Promoter ― 0.01
Dec '2533.50% Feb '26*33.51% Mar '2633.51% Jun '2633.51%

Promoter held steady from 33.50% to 33.51% across these quarters.

FII ▲ 3.55
Dec '2538.84% Feb '26*40.32% Mar '2641.78% Jun '2642.39%

FII rose from 38.84% to 42.39% across these quarters.

MF ▲ 0.89
Dec '257.68% Feb '26*7.58% Mar '267.23% Jun '268.57%

MF rose from 7.68% to 8.57% across these quarters.

Other ▼ 4.45
Dec '2519.98% Feb '26*18.59% Mar '2617.48% Jun '2615.53%

Other trimmed from 19.98% to 15.53% across these quarters.

Working capital12-year series

Where cash gets stuck. A rising inventory or debtor line against flat sales is the earliest sign of trouble in the numbers.

MeasureFY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Debtor days
How long customers take to pay
195121115121124138121126
Inventory days
How long stock sits before it sells
306153180216187198155179
Payable days
How long the company takes to pay suppliers
330199244274236196164169
Cash conversion cycle
Debtor + inventory − payable days
17175516476141113135
Working capital days127595236465295
ROCE %
Return on capital employed
10.0%10.0%13.0%14.0%14.0%3.0%8.0%10.0%

Agri vitalsthe numbers this business is run on

Quarter by quarter

MetricQ2 FY27Q2 FY26
Volumes (mt)-100
Channel inventory days (days)145118
Q2 Contribution Margin42.9%41.9%
Days Inventory Outstanding (days)140124
Days Sales Outstanding (DSO) (days)150146
Trailing 12-Month Net Debt to EBITDA (x)2.92.7
Structural Debt (Net Debt less Net Working Capital) ($ million)800—

From the quarterly results and the earnings call, read by FinMinutes. Latest quarter, read in full.

Read using the Agriculture, fertilisers and agrochemicals framework (named in the filing read). Primary valuation lens: P/E through the season.

Read more closely in this sector: Age of subsidy receivables · Channel inventory build.

Trends

The shape of the business over time (annual) — read the direction, not the single print.

Revenue (₹ cr)
FY202138.7kFY202246.2kFY202353.6kFY202443.1kFY202546.6kFY202651.8k
Net profit (₹ cr)
FY20213.5kFY20224.4kFY20234.4kFY2024-1.9kFY2025820FY20262.2k

Annual Profit & Loss ₹ cr

LineFY2021FY2022FY2023FY2024FY2025FY2026
Revenue from operations38,69446,24053,57643,09846,63751,839
Other income629146423178724
Depreciation2,1732,3592,5472,7632,7503,244
Finance cost2,0602,2952,9633,8523,6273,401
Profit before tax4,1814,9665,150-2,0878293,157
Net profit (owners)3,4954,4374,414-1,8788202,220
EPS (₹)33.4042.1842.28-14.2110.6222.78

Exceptional items, total income and EBITDA are read from the filed statements.

Quarterly Financials ₹ cr

MetricSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue10,1709,88714,0789,06711,09010,90715,5739,21612,01912,26918,33510,181
Other Income18134664910394-16815239236162208
Expenses9,0499,82012,2307,9989,8739,22912,4097,82010,07210,03314,8548,814
Depreciation657676794660697688705731771827915832
Finance cost8711,1911,0909131,0707309141,007784774836852
Profit before tax-389-1,66630-455-4473541,377-1907846711,892-109
Net Profit-293-1,607-80-527-5858531,079-1766124901,294-73
EPS-2.24-14.410.47-4.55-5.259.8110.61-1.046.564.7012.570.12

Balance Sheet ₹ cr, annual

ItemFY2021FY2022FY2023FY2024FY2025FY2026
Equity Capital153153150150159169
Reserves20,73424,50826,70824,65729,05434,527
Borrowings24,51926,74623,93929,75425,09923,576
Net block34,76536,19338,71339,05639,08442,153
CWIP2,1172,5012,8182,9652,5463,147
Investments6181,9221,6152,1542,3282,666
Total Assets68,76580,60386,11585,14086,01293,119

Cash Flow ₹ cr

LineFY2021FY2022FY2023FY2024FY2025FY2026
Cash from operations7,2126,4967,7512,32110,1517,855
Cash from investing-2,426-3,575-1,354-2,509-1,823-1,475
Cash from financing-6,713-1,921-6,227164-4,793-9,883
Free cash flow5,1473,9315,4623678,8965,502
Net change in cash-1,9271,000170-243,535-3,503

Cash from operations is the number profit has to answer to. Free cash flow is what remains after the business pays for its own growth.

From the filings, calls & disclosures

The part no one reads: the auditor's opinion, the contingent liabilities buried in the notes, the covenants, and the claims in the deck placed beside the figures that test them.

  • Buried in the footnotes — what the notes disclose and the summary does not
  • Risk register — every dispute, probe and contingent liability with its amount
  • Audit & governance — opinion type, emphasis of matter, going concern, subsidiary coverage
  • Guidance & forward view
  • Narrative vs numbers
  • Segment intelligence
Live once this company's filings, calls and disclosures have been read.
The analyst grilling

Where analysts pressed management on the earnings call, and exactly how management answered — the questions that were hardest to answer are usually the ones that matter.

  • The question, and who asked it
  • Management's answer, in their own framing
Live once this company's filings, calls and disclosures have been read.

Disclosure & evidencewhat the filings actually show

These are coverage counts, not ratings. Each one asks a fixed set of questions of the filings and reports how many the company answered. A company that discloses nothing counts nothing here — that is a statement about the disclosure, not about the business.

Capital discipline

3 of 4 disclosed weighted 8 of 10
What was looked for
  • Profit converts to cash — 2.64× over 12 years
  • Free cash flow not persistently negative — 0 of 12 years negative
  • Capital converts into revenue — capital +9% vs revenue +-3%
  • Interest comfortably covered — 1.93×

Others in Chemicals

The same read, applied to the companies this one competes with.

Results · Q2 FY27July to September 2026

Open the full results page ↗
!1 serious?2 questions to ask15 of 19 checks ran · read from the filing
Revenue₹11,860 cr▼ 1.3%on the year▲ 16.5%on the quarter
EBITDA₹2,200 cr▲ 9.9%on the yearmargin 18.5% (+190 bps)
Net profit₹452 cr▼ 26.1%on the year
EPS₹4.99▼ 26.1%on the year

What changed

  1. Revenue ₹11,860 cr, −1.3% on the year (this quarter has averaged +8.7% over the last 2 years); EBITDA margin 18.5%, +190 bps.
  2. Part of the profit growth came from outside the business: reported −26.1%, core −36.7%. Other income, exceptional items or tax added 11 points.
  3. Profit with no operating cash behind it. Where did the cash go? Operating cash flow for the first half −₹9,587 cr against profit of ₹379 cr.

The quarter, explainedfrom the filing and the statements

UPL Ltd. reported revenue of ₹11,860 cr for July to September 2026, −1.3% on the year and +16.5% on the quarter. That is slower than this quarter has grown in recent years (+8.7% on average). Over the last four quarters revenue comes to ₹52,645 cr, +10.3% on the four before.

Operating profit (EBITDA) was ₹2,200 cr, a margin of 18.5%, +190 bps on the year and +431 bps on the quarter. Over the last 8 quarters the margin has ranged from 14.2% to 20.3%, averaging 17.2%. Operating costs grew −3.6% against revenue growth of −1.3%, so more of each rupee of sales reached operating profit.

Net profit was ₹452 cr, −26.1% on the year and — on the quarter, with earnings per share of ₹4.99. Profit before other income, one-offs and tax fell 36.7%, so 11 points of the headline growth came from outside the core business. The tax rate of 27% is in line with its recent average. Profit over the last four quarters totals ₹2,163 cr, −8.7% on the four before.

Of the 3 companies in Agriculture, fertilisers and agrochemicals that have reported Q2 FY27 so far, UPL Ltd. ranks 2nd on revenue growth; the sector median is −6.4%. Its margin moved +190 bps on the year against a sector median of +65 bps.

Agri inputs are seasonal and move with the monsoon and with subsidy payments, so quarters are best compared with the same quarter a year earlier.

On earnings per share of ₹22.38 over the last four quarters, the stock at ₹534.65 trades at 23.9 times trailing earnings.

Questions to askeach one with its numbers and source

!Serious

Profit with no operating cash behind it. Where did the cash go?

Operating cash flow for the first half −₹9,587 cr against profit of ₹379 cr.

Source: Cash flow statement

What the company says
“Net Working Capital Days Q2 FY27 (145 days, +27 days YoY) up: Driven by a 16-day increase in inventory days from higher input costs, lower crop volumes, and H2 inventory build-up.”
Earnings call, transcript p.10-11
?Question

Inventory is piling up against sales. Slow demand, or stocking ahead?

Inventory at 167 days of sales, against 89 days at the last year end (₹20,165 cr now, ₹12,676 cr then).

Source: Balance sheet

What the company says
“Net Working Capital Days Q2 FY27 (145 days, +27 days YoY) up: Driven by a 16-day increase in inventory days from higher input costs, lower crop volumes, and H2 inventory build-up.”
Earnings call, transcript p.10-11
?Question

Receivables grew much faster than sales. Who has not paid, and why?

Receivables at 154 days of sales, against 129 days at the last year end (₹18,638 cr now, ₹18,343 cr then).

Source: Balance sheet

What the company says
“Net Working Capital Days Q2 FY27 (145 days, +27 days YoY) up: Driven by a 16-day increase in inventory days from higher input costs, lower crop volumes, and H2 inventory build-up.”
Earnings call, transcript p.10-11

Could not run on this quarter: IPO money used as stated, Related-party transactions, Promoter pledges and allotments, Earlier promises against delivery. The filing did not carry these lines.

Where the profit change came fromSep '25 → Sep '26

₹612 crSep'25+₹199 crBusiness(EBITDA)−₹48.0 crDepreciation−₹35.0 crFinancecost−₹64.0 crOtherincome+₹143 crExceptionalitems+₹9.0 crTax−₹364 crOtherlines₹452 crSep'26Scale starts at ₹234 cr, not zero, so the changes are visible

Net profit a year ago, each driver's change, and net profit now. Blue added profit, red took it away.

The half year: balance sheet and cashfiled with Q2

Balance sheetSep '26Last year endChange
Trade receivables₹18,638 cr₹18,343 cr▲ 1.6%
Inventory₹20,165 cr₹12,676 cr▲ 59.1%
Cash₹3,268 cr₹5,975 cr▼ 45.3%
Bank balances₹64.0 cr₹111 cr▼ 42.3%
Long-term borrowings₹10,926 cr₹15,535 cr▼ 29.7%
Short-term borrowings₹21,789 cr₹6,511 cr▲ 234.6%
Trade payables₹14,046 cr₹12,018 cr▲ 16.9%
Net block₹8,321 cr₹8,474 cr▼ 1.8%
Capital work in progress₹1,308 cr₹999 cr▲ 30.9%
Equity₹34,824 cr₹34,696 cr▲ 0.4%
Total assets₹1.01 lakh cr₹95,205 cr▲ 6.1%
Cash flow, year to dateThis yearLast year
Operating cash flow−₹9,587 cr−₹4,811 cr
Capital expenditure−₹798 cr−₹989 cr
Investing cash flow−₹1,270 cr−₹793 cr
Financing cash flow₹8,124 cr−₹155 cr
Dividends paid−₹507 cr−₹478 cr

Operating cash flow was -25.30× profit. Receivables at 154 days of sales (+25 days against the last year end). Inventory at 167 days of sales (+78 days).

From the filingauditor, IPO money, related parties, promoters

✓Auditor's reviewUnmodified conclusion · B S R & Co. LLP

Other matter 1: “

We did not review the financial information of 31 Subsidiaries included in the Statement, whose financial information reflects total assets (before consolidation adjustments) of Rs. 1,28,894 crores as at 30 September 2026 and total revenues (before consolidation adjustments) of Rs.… Read in fullWe did not review the financial information of 31 Subsidiaries included in the Statement, whose financial information reflects total assets (before consolidation adjustments) of Rs. 1,28,894 crores as at 30 September 2026 and total revenues (before consolidation adjustments) of Rs. 8,444 crores and Rs. 14,784 crores, total net profit after tax (before consolidation adjustments) of Rs. 4,344 crores and Rs. 9,201 crores and total comprehensive income (before consolidation adjustments) of Rs. 4,349 crores and Rs. 9,208 crores, for the quarter ended 30 September 2026 and for the period from 01 April 2026 to 30 September 2026 respectively, and net cash outflows (before consolidation adjustments) of Rs. 1,020 crores for the period from 01 April 2026 to 30 September 2026 as considered in the Statement.
”

Other matter 2: “

The Statement includes the interim financial information of 153 Subsidiaries which have not been reviewed, whose interim financial information reflects total assets (before consolidation adjustments) of Rs. 1,65,257 crores as at 30 September 2026 and total revenues (before consolidation adjustments)… Read in fullThe Statement includes the interim financial information of 153 Subsidiaries which have not been reviewed, whose interim financial information reflects total assets (before consolidation adjustments) of Rs. 1,65,257 crores as at 30 September 2026 and total revenues (before consolidation adjustments) of Rs. 4,818 crores and Rs. 10,108 crores, total net profit after tax (before consolidation adjustments) of Rs. 2,511 crores and Rs. 2,958 crores and total comprehensive income (before consolidation adjustments) of Rs. 2,509 crores and Rs. 2,956 crores, for the quarter ended 30 September 2026 and for the period from 01 April 2026 to 30 September 2026 respectively, and net cash outflows (before consolidation adjustments) of Rs. 1,076 crores for the period from 01 April 2026 to 30 September 2026 as considered in the Statement. The Statement also includes the Group's share of net loss after tax of Rs. 132 crores and Rs. 215 crores and total comprehensive loss of Rs. 130 crores and Rs. 207 crores for the quarter ended 30 September 2026 and for the period from 01 April 2026 to 30 September 2026 respectively as considered in the Statement, in respect of 17 associates and 6 joint ventures, based on their interim financial information which have not been reviewed.
”

Filing p. limited review report p.1-2

?Governance eventsOther

Composite Scheme of Arrangement approved for amalgamation of UPL SAS into UPL Ltd, demerger into UPL Global, and amalgamation of UPLCL into UPL Global; received observation letters from BSE & NSE on July 29, 2026. (p. consolidated note 7)

Inside the profitother income, one-offs, tax

Other income, line by line

  • Reversal of provision relating to VAT refund receivables of a subsidiary: 75.00 crore (one-off)consolidated note 6(b)
  • Other operating income towards settlement for early termination of job work manufacturing arrangement: 57.00 crore (one-off)consolidated note 10
  • Unwinding of interest on trade payables and trade receivables (6M consolidated): 312.00 crore (recurring)consolidated cash flow statement
  • Interest income on loans and others (6M consolidated): 212.00 crore (recurring)consolidated cash flow statement

One-offs

  • Restructuring cost (including severance cost and impairment): 1.00 crore. Seen before: 1consolidated note 4

Tax: Consolidated tax expense of ₹163.00 crore (current tax ₹330.00 crore, deferred tax credit ₹167.00 crore) on Profit before tax of ₹615.00 crore

Agri vitalsthe numbers this business is run on

MetricQ2 FY27Q2 FY26
Volumes (mt)-100
Channel inventory days (days)145118
Q2 Contribution Margin42.9%41.9%
Days Inventory Outstanding (days)140124
Days Sales Outstanding (DSO) (days)150146
Trailing 12-Month Net Debt to EBITDA (x)2.92.7
Structural Debt (Net Debt less Net Working Capital) ($ million)800—

Checks this sector needs

iAge of subsidy receivables

not disclosed

Government subsidy receivables are not applicable as UPL is an agrochemical and seed solutions provider rather than a subsidized fertilizer manufacturer.

?Channel inventory build

Consolidated net working capital expanded by 27 days YoY to 145 days, led by DIO increasing 16 days to 140 days (inventory at ₹20,165 crore) due to seasonal H2 build-up, lower crop protection volumes, and Latin America/Europe channel illiquidity.

Inventory accumulation and working capital expansion reflect persistent channel illiquidity in LATAM and weather disruptions in Europe.

Read using the Agriculture, fertilisers and agrochemicals framework (named in the filing read). Primary valuation lens: P/E through the season.

1 standard read withheld or marked as expected here, and why
  • Quarters swing with the season or with project milestones here; read the year, not the quarter.

Read more closely in this sector: Age of subsidy receivables · Channel inventory build.

What the company says drove itfrom the presentation and press release

  • Consolidated Q2 FY27 Revenue (₹11,860 crore, -1% YoY) down: 10% volume decline in global crop protection offset by 9% positive currency contribution and double-digit growth in Advanta and Superform.transcript p.8
  • Consolidated Q2 FY27 EBITDA (₹2,312 crore, +5% YoY) up: Margin expansion of 120 bps to 19.5% from improved product/platform mix, brand strength, and SG&A cost optimization.transcript p.9
  • Superform Revenue Q2 FY27 (₹3,579 crore, +28% YoY) up: Driven by 50% growth in specialty chemicals (33% volume, 17% price) and active ingredient price pass-through (+21%).transcript p.13
  • Superform EBIT Q2 FY27 (₹323 crore, +39% YoY) up: Driven by price realization, higher share of specialty chemicals (29% vs 25%), and strong lubricant contract manufacturing.transcript p.14
  • UPL Corp Q2 FY27 Revenue (₹7,972 crore, -8% YoY) down: Impacted by 16% volume decline and 2% price decline due to tight LATAM grower credit, European heatwave, and cautious buying.transcript p.14-15
  • Advanta Q2 FY27 Revenue (₹1,875 crore, +12% YoY) up: Driven by field corn in Argentina, LATAM, and Indonesia, sunflower and grain sorghum in Argentina, and post-harvest growth.transcript p.18
  • UPL SAS H1 FY27 EBITDA (₹553 crore, +20% YoY) up: Driven by 430 bps margin expansion to 26.8% from 9% price realization and 80% growth in hyper-scale brands.transcript p.17
  • Net Working Capital Days Q2 FY27 (145 days, +27 days YoY) up: Driven by a 16-day increase in inventory days from higher input costs, lower crop volumes, and H2 inventory build-up.transcript p.10-11

From the investor presentationthe operating tables, as printed

Platform Revenue Performance (Q2 FY27) (₹ crore)

This quarterYoY
Superform (Manufacturing & Specialty Chemicals)3579.00+28.0%
UPL Corp (Global Crop Protection)7972.00−8.0%
UPL SAS (India Crop Protection)921.00+1.0%
Advanta (Seeds & Post-Harvest)1875.00+12.0%

Source: transcript p.13, 14, 16, 18

Platform EBITDA / EBIT Performance (Q2 FY27) (₹ crore)

This quarterYoY
Superform EBIT323.00+39.0%
UPL Corp EBITDA1083.00—
UPL SAS EBITDA214.00+3.0%
Advanta EBITDA510.00+19.0%

Source: transcript p.14, 16, 17, 19

First Half (H1 FY27) Platform Performance (₹ crore)

This quarterYoY
Advanta H1 Revenue3629.00+18.0%
Advanta H1 EBITDA868.00+21.0%
UPL Crop H1 Revenue14345.00−2.0%
UPL SAS H1 EBITDA553.00+20.0%

Source: transcript p.16, 17, 19

What management saidquoted, with source

  • UPL delivered its eighth consecutive quarter of improvement in margins and EBITDA grew 5% in the quarter and 9% in the first half with margins expanding by 120 and 80 basis points.concall, transcript p.3
  • Advanta, our seeds and post-harvest platform, has agreed to acquire 99.98% of Misr Hytech Seed International in Egypt for approximately $110 million.concall, transcript p.7
  • S&P revised the outlook on UPL Corp to positive from stable affirming its BB rating and CRISIL revised the outlook on UPL Limited to stable affirming its AA+ and A1+ ratings.concall, transcript p.8
  • Of the $500 million term loan maturing in December 2026, we have refinanced $400 million to FY32, well ahead of the schedule.concall, transcript p.8
  • We reported revenue of 11,860 crore, stable at 1% lower than last year. Volumes declined by 10%, pricing was flat and currency contributed a positive 9%.concall, transcript p.8
  • Superform grew revenue by an outstanding 28% to 3,579 crore with pricing up 26% and volumes up 2%.concall, transcript p.13
  • For the first half, UPL SAS EBITDA grew a sharp 20% to 553 crore with margin expanding 430 basis points to 26.8%.concall, transcript p.17
  • Structural debt stood at around $800 million as of 30th September 2026 against a reported net debt of approximately $3 billion which translates to a healthy 0.7x gearing.concall, transcript p.12

Guidance given this quarter

MetricGuidanceForAgainst earlier guidance
Revenue Growth Guidance7.00–11.00 %FY2027was maintained (reconfirmed comfortable with guidance)
EBITDA Growth Guidance10.00–14.00 %FY2027was maintained (reconfirmed comfortable with guidance)
Net Debt to EBITDA Target1.50–1.50 xMedium-termwas maintained
Capex and Growth Investment Guidance425.00FY2027was maintained

Held for next quarter's said-then-did check.

From the call

  • Delivered eighth consecutive quarter of margin improvement with Q2 FY27 EBITDA up 5% YoY to ₹2,312 crore and margin expanding 120 bps to 19.5%.transcript p.3, 9
  • H1 FY27 revenue reached ₹22,041 crore (+4% YoY), supported by double-digit growth in Advanta (+18%) and Superform (+21%).transcript p.8, 9
  • Advanta agreed to acquire 99.98% of Misr Hytech Seed International in Egypt for ~$110 million to expand in field corn across Middle East and Africa.transcript p.7
  • Prepaid $500 million term loan maturing December 2026 and refinanced $400 million out to FY32 ahead of schedule.transcript p.8, 47
  • S&P revised UPL Corp outlook to positive (BB affirmed) and CRISIL revised UPL Ltd outlook to stable (AA+/A1+ affirmed).transcript p.8
  • Reported net debt stood at ~$3 billion, up $312 million YoY due to seasonal working capital, planned capex, and JV investments.transcript p.10

Where analysts pushed

QuestionAnswerAnswered?
Are you going ahead with the corporate reorganization scheme or open to reworking it given negative market perception?Management stated they cannot comment on this call but will update the market in accordance with listing obligations if there are material developments.deflected
Why is LIC nominating a director on the board at this time?LIC is a long-term shareholder and NRC felt bringing senior LIC expertise in finance/risk enhances overall board governance; timing should not be misconstrued.yes
Are the ₹75 crore VAT provision reversal and ₹57 crore corporate settlement one-off items that should be in exceptional?VAT reversal was an operational working capital provision reversal, and the ₹57 crore settlement was an operational take-or-pay contract termination fee.yes
When will higher Chinese glufosinate and technical prices reflect in higher realizations in Americas markets?Price increases will take effect in Americas once lower-cost channel inventory liquidates during the ongoing season.yes
What was the factoring amount this quarter and what is the net debt and capex guidance?Factoring was ~$70 million lower YoY; capex and growth investment guidance remains $425 million, with medium-term net debt to EBITDA target at 1.5x.partly
Why did employee expenses decline 15% YoY in Q2?Driven by GBS transition (headcount up 3x across lower-cost hubs in Pune, Colombia, Mauritius), target operating model cost savings, and FX devaluation.yes

Tone against the last call. Management shifted from focusing solely on reported net debt reduction targets to introducing 'structural debt' ($800 million / 0.7x gearing) to explain working capital expansion.

Plans, launches and capacityfrom the call and presentation

  • Acquisition of Misr Hytech Seed International in Egypt: 99.98% stake for ~$110 million (Q2 FY2027), under waytranscript p.7, 44-45
  • Term Loan Refinancing to FY32: $400 million refinanced out of $500 million December 2026 maturity (Q2 FY2027), completedtranscript p.8, 47
  • Global Business Services (GBS) Capacity Expansion: Headcount expanded 3x across Pune, Colombia, and Mauritius centers (H1 FY2027), completedtranscript p.43, 51
  • Superform Specialty Chemicals Contract Manufacturing Commercialization: Specialty volume up 33%, platform EBIT up 39% to ₹323 crore (Q2 FY2027), under waytranscript p.13-14, 42

Segments

SegmentRevenueYoYResultYoY
Crop protection₹9,034 cr▼ 7.2%₹1,214 cr▲ 9.1%
Seeds & Post harvest₹1,858 cr▲ 10.9%₹425 cr▲ 24.6%
Non agro₹1,060 cr▲ 61.8%₹154 cr▲ 38.7%

The readsynthesis of the filing and the call, no new facts

UPL delivered Q2 FY27 revenue of ₹11,860 crore (-1% YoY) and H1 FY27 revenue of ₹22,041 crore (+4% YoY), supported by double-digit growth in Advanta (+12%) and Superform (+28%) which cushioned a 16% volume drop in global crop protection (UPL Corp). Operational net profit reached ₹422 crore in Q2, driven by an eighth consecutive quarter of EBITDA margin expansion (+120 bps to 19.5%) and SG&A cost optimization. However, operating cash flow was constrained as net working capital expanded by 27 days to 145 days, pushing reported net debt to ~$3 billion. UPL mitigated refinancing risk by extending $400 million of debt to FY32. What remains unresolved is the working capital unwinding trajectory in LATAM and the final timeline for the corporate reorganization scheme.

What matters most. Normalization of working capital and liquidation of high-cost channel inventory in LATAM during H2 to convert inventory into cash flow and reduce reported net debt.

What would change it. Further expansion in working capital days beyond 145 days or persistent volume contraction in UPL Corp during the peak H2 season.

Headline findings

  • Net working capital expanded by 27 days YoY to 145 days, driving reported net debt up by $312 million to ~$3 billion.transcript p.10, 11
  • Global crop protection (UPL Corp) volumes dropped 16% YoY in Q2 FY27 due to grower credit constraints in LATAM and European heatwave.transcript p.14, 15
  • Management deflected questions regarding the status and potential reworking of the corporate reorganization scheme.transcript p.23-25
  • Prepaid $500 million term loan due December 2026 and successfully refinanced $400 million out to FY32.transcript p.8, 47
  • Delivered eighth consecutive quarter of margin expansion, with Q2 EBITDA up 5% YoY to ₹2,312 crore and margin expanding 120 bps to 19.5%.transcript p.3, 9

Open questions

  • When will regulatory approvals and shareholder voting for the corporate reorganization scheme be completed?Regulatory exchange filings and statutory meeting notices
  • Will net working capital days normalize back toward ~120 days by FY27 year-end?Q3 FY27 financial results and investor presentation
  • What are the key financial terms (revenue and EBITDA multiples) for the Misr Hytech acquisition upon closing?Post-closing press release or Q3 FY27 concall transcript
  • How quickly will Chinese glufosinate and technical AI price hikes translate into higher realizations in LATAM and US markets?Q3 FY27 platform performance commentary for UPL Corp and Superform

Every quartersame rules, every quarter

Q3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26Q4 FY26Q1 FY27Q2 FY27
Revenue₹9,887 cr₹14,078 cr₹9,067 cr₹11,090 cr₹10,907 cr₹15,573 cr₹9,216 cr₹12,019 cr₹12,269 cr₹18,335 cr₹10,181 cr₹11,860 cr
YoY——+1%+9%+10%+11%+2%+8%+12%+18%+10%−1%
EBITDA margin0.7%13.1%11.8%11.0%15.4%20.3%15.1%16.6%18.2%19.0%14.2%18.5%
Other income, % of PBT—220%——27%−12%—32%5%9%—30%
Exceptional items———————−₹142 cr——₹9.0 cr₹1.0 cr
Tax rate—————22%—22%27%32%—27%
Net profit−₹1,607 cr−₹80.0 cr−₹527 cr−₹585 cr₹853 cr₹1,079 cr−₹176 cr₹612 cr₹490 cr₹1,294 cr−₹73.0 cr₹452 cr
YoY——−617%—————−43%+20%—−26%
Core profit YoY————————+144%+12%—−37%
EPS−₹14.41₹0.47−₹4.55−₹5.25₹9.81₹10.61−₹1.04₹6.75₹4.70₹12.57₹0.12₹4.99
Flags·11✓✓1✓1✓✓✓3

Each quarter is read with the same rules. Balance-sheet and cash checks run on half-year and annual quarters; filing-read checks run where a read exists.

DISCLAIMER: FinMinutes is a financial data and analytics platform, not a registered investment adviser. Everything here is for educational and informational purposes. Forensic interpretations are computed from disclosed data and are not recommendations. Do your own due diligence.
Chat on WhatsApp